KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Current Assets (2016 - 2025)

Elevance Health (ELV) has disclosed Current Assets for 17 consecutive years, with $63.8 billion as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 1.48% to $63.8 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $63.8 billion, a 1.48% increase, with the full-year FY2024 number at $58.9 billion, down 1.81% from a year prior.
  • Current Assets was $63.8 billion for Q3 2025 at Elevance Health, up from $63.3 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $63.8 billion in Q3 2025 to a low of $50.2 billion in Q2 2021.
  • A 5-year average of $57.9 billion and a median of $59.7 billion in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: surged 32.09% in 2021, then fell 1.81% in 2024.
  • Elevance Health's Current Assets stood at $51.1 billion in 2021, then increased by 8.79% to $55.6 billion in 2022, then rose by 7.93% to $60.0 billion in 2023, then fell by 1.81% to $58.9 billion in 2024, then increased by 8.2% to $63.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Current Assets are $63.8 billion (Q3 2025), $63.3 billion (Q2 2025), and $61.1 billion (Q1 2025).